{"gene":"H1-10","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2005,"finding":"H1X (H1x) localizes to the nucleus and is partially associated with nucleosomes; it is predominantly found in chromatin regions resistant to micrococcal nuclease digestion, resembling the distribution of the replacement histone H1.0. Its gene is solitarily located and produces polyadenylated mRNA, but unlike H1.0, its expression is not induced by growth arrest or differentiation.","method":"Cell fractionation, micrococcal nuclease digestion, mRNA analysis (biochemical characterization)","journal":"Biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical methods (fractionation, MNase digestion, mRNA analysis) in a single study; directly characterizes H1X chromatin association and expression regulation","pmids":["16006241"],"is_preprint":false},{"year":2007,"finding":"H1X undergoes a cell-cycle-dependent change in nuclear distribution: it accumulates in the nucleolus (specifically in condensed nucleolar chromatin) during G1 phase and is evenly distributed throughout the nucleus during S and G2 phases. The amount of H1X protein remains nearly unchanged during S phase, in contrast to replication-dependent H1 subtypes.","method":"Immunocytochemistry, cell synchronization, cell-cycle staging","journal":"Biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct imaging with cell-cycle synchronization in a single lab, multiple cell-cycle stages examined, clear functional implication of compartment shuttling as regulatory mechanism","pmids":["17868027"],"is_preprint":false},{"year":2010,"finding":"During retinoic acid-induced differentiation of NT2 embryonal carcinoma cells, H1X is preferentially incorporated into the regulatory region of the Nanog gene (a stemness marker that is repressed upon differentiation), suggesting a repressive role for H1X at this locus.","method":"Chromatin immunoprecipitation (ChIP) coupled with real-time PCR, Western blot","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, ChIP-qPCR demonstrates H1X occupancy at Nanog promoter correlated with gene repression during differentiation; mechanistic link inferred but not fully dissected","pmids":["20974140"],"is_preprint":false},{"year":2015,"finding":"ChIP-sequencing and cell fractionation in human breast cancer cells revealed that H1X is associated with coding regions, RNA polymerase II-enriched regions, and hypomethylated CpG islands; it accumulates within constitutive or included exons and retained introns and toward the 3' end of expressed genes. H1X knockdown dysregulates a subset of genes related to cell movement and transport; up-regulated genes in H1X-depleted cells have lower-than-average H1 content and do not form an H1 valley upon induction.","method":"ChIP-sequencing, cell fractionation, inducible knockdown, gene expression analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-Seq plus functional knockdown with defined transcriptional phenotype, multiple orthogonal methods","pmids":["25645921"],"is_preprint":false},{"year":2019,"finding":"NMR backbone resonance assignments of the H1X N-terminal domain and globular domain show that the N-terminal domain adopts transient alpha-helical secondary structural elements at high ionic strength (in the presence of sodium perchlorate), suggesting the N-terminal domain can assume structured conformations in conditions mimicking the presence of DNA.","method":"Solution NMR (backbone resonance assignment, chemical shift analysis)","journal":"Biomolecular NMR assignments","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — NMR structural characterization in a single study; functional consequence is inferred from chemical shift changes rather than directly tested","pmids":["30868366"],"is_preprint":false},{"year":2022,"finding":"The histone chaperone TAF-Iβ recognizes H1.10 (H1X) in a 2:2 complex; the TAF-Iβ core interacts mainly through electrostatic interactions with the globular domain of H1.10. Structure-guided mutagenesis confirmed these interactions. The structural model shows that TAF-Iβ occludes the DNA-binding sites of H1.10, providing the mechanism by which TAF-Iβ functions as a chaperone by preventing H1.10 from directly binding DNA.","method":"Methyl-TROSY NMR with spin labels, biochemical binding assays, mutagenesis, structural modeling, comparison with chromatosome structure","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR-derived structural model with mutagenesis confirmation and mechanistic explanation (DNA-site occlusion); multiple orthogonal biophysical and biochemical methods in a single rigorous study","pmids":["35870650"],"is_preprint":false},{"year":2024,"finding":"ChIP-Seq profiling in a breast cancer cell line shows H1X preferentially localizes in high-GC regions (A compartment) and is enriched at recently incorporated transposable elements (SVA and SINE-Alu families). H1X depletion leads to derepression of these transposable elements, demonstrating a direct role for H1X in maintaining TE repression.","method":"ChIP-Seq, H1X knockdown/depletion, transposable element expression analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-Seq combined with functional depletion showing TE derepression, consistent across multiple cell lines; replicated genomic localization finding from earlier ChIP-Seq study","pmids":["38261975"],"is_preprint":false},{"year":2024,"finding":"Super-resolution imaging and imaging analysis in multiple human cell lines show that H1X is distributed throughout the nucleus and is universally enriched in high-GC regions and in nucleoli. H1X (but not other H1 variants) shows a distinct response to inhibition of ribosomal DNA transcription, linking its nucleolar enrichment to active rDNA transcription. H1 variant depletion affects chromatin structure in a variant-specific manner.","method":"Super-resolution microscopy, immunofluorescence, rDNA transcription inhibition, multiple cell lines","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by super-resolution microscopy across multiple cell lines with functional perturbation (rDNA transcription inhibition); single lab but multiple orthogonal imaging approaches","pmids":["38530350"],"is_preprint":false},{"year":2024,"finding":"MEF2D transcription factor directly binds the H1X promoter and drives transcriptional activation of H1X in gastric cancer cells. H1X upregulation in turn promotes in vivo metastasis of gastric cancer cells and upregulates β-CATENIN. The IL-13/IL13RA1 signaling axis induces MEF2D and H1X expression in a time-dependent manner.","method":"Chromatin immunoprecipitation (ChIP), promoter-binding assay, overexpression/knockdown, proteomics, mouse metastasis models, quantitative RT-PCR","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrates direct MEF2D binding to H1X promoter; functional consequence shown by OE/KD in mouse models; single lab with multiple methods","pmids":["38609001"],"is_preprint":false},{"year":2024,"finding":"Overexpression of H1X in the mouse ventral hippocampus via viral vector does not produce behavioral changes (social, anxiety-like, or memory tests) in susceptible, resilient, or unstressed mice, indicating that elevated H1X alone is not sufficient to drive behavioral adaptations to chronic social stress.","method":"Viral vector overexpression in vivo, chronic social defeat stress paradigm, behavioral testing","journal":"Translational psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct in vivo gain-of-function experiment with clear negative behavioral result; single lab, single approach; negative finding is mechanistically informative (H1X elevation is not causally sufficient)","pmids":["38834575"],"is_preprint":false}],"current_model":"H1X (H1-10) is a replication-independent linker histone variant that associates with nucleosomes in micrococcal nuclease-resistant chromatin, preferentially occupies high-GC genomic regions (A compartment), RNA Pol II-enriched gene bodies, and nucleoli, and undergoes cell-cycle-dependent nucleolar accumulation during G1; its chaperone TAF-Iβ binds the H1X globular domain via electrostatic interactions in a 2:2 complex that occludes DNA-binding sites, thereby regulating H1X deposition onto chromatin, while H1X itself represses recently incorporated transposable elements (SVA and Alu) and contributes to gene regulation—including repression at the Nanog locus during differentiation—and its transcription is directly activated by MEF2D downstream of IL-13/IL13RA1 signaling."},"narrative":{"mechanistic_narrative":"H1-10 (H1X) is a replication-independent linker histone variant that partitions into specific genomic compartments to shape chromatin structure and gene regulation [PMID:16006241, PMID:25645921]. Unlike replication-dependent H1 subtypes, its abundance is stable through S phase, and it shuttles into nucleolar chromatin during G1 phase [PMID:17868027], with nucleolar enrichment coupled to active rDNA transcription [PMID:38530350]. Genome-wide profiling places H1X in high-GC, RNA polymerase II-enriched coding regions and hypomethylated CpG islands, biased toward exons and the 3' ends of expressed genes, where its depletion dysregulates genes linked to cell movement and transport [PMID:25645921]. H1X preferentially occupies high-GC A-compartment regions and recently incorporated transposable elements, and its loss derepresses SVA and SINE-Alu elements, establishing a direct role in transposon silencing [PMID:38261975]; it likewise contributes to locus-specific repression, occupying the Nanog regulatory region during retinoic acid-induced differentiation [PMID:20974140]. Deposition of H1X onto chromatin is governed by the histone chaperone TAF-Iβ, which binds the H1X globular domain through electrostatic contacts in a 2:2 complex that occludes its DNA-binding sites [PMID:35870650]. H1X transcription is directly activated by MEF2D downstream of IL-13/IL13RA1 signaling, driving β-CATENIN upregulation and gastric cancer metastasis [PMID:38609001].","teleology":[{"year":2005,"claim":"Established H1X as a distinct linker histone variant by showing it associates with MNase-resistant chromatin like H1.0 yet, unlike H1.0, is not induced by growth arrest or differentiation.","evidence":"Cell fractionation, MNase digestion, and mRNA analysis","pmids":["16006241"],"confidence":"Medium","gaps":["Did not define genomic targets or chromatin compartments occupied","Regulatory function not tested"]},{"year":2007,"claim":"Revealed cell-cycle-dependent subnuclear dynamics, showing H1X accumulates in nucleolar chromatin during G1 while remaining stable in abundance through S phase, distinguishing it from replication-coupled H1.","evidence":"Immunocytochemistry with cell synchronization across cell-cycle stages","pmids":["17868027"],"confidence":"Medium","gaps":["Mechanism driving G1 nucleolar relocalization unknown","Functional consequence of nucleolar accumulation not established"]},{"year":2010,"claim":"Linked H1X to locus-specific gene repression by showing it is incorporated into the Nanog regulatory region as the gene is silenced during differentiation.","evidence":"ChIP-qPCR and Western blot in retinoic acid-differentiated NT2 cells","pmids":["20974140"],"confidence":"Medium","gaps":["Causal repressive role inferred from occupancy correlation, not direct perturbation","Recruitment mechanism to Nanog locus unknown"]},{"year":2015,"claim":"Defined the genome-wide distribution of H1X, placing it in RNA Pol II-enriched coding regions and hypomethylated CpG islands and tying its depletion to a defined transcriptional phenotype.","evidence":"ChIP-Seq, cell fractionation, and inducible knockdown with expression profiling in breast cancer cells","pmids":["25645921"],"confidence":"High","gaps":["Did not identify how H1X is targeted to these regions","Direct vs indirect effects on dysregulated genes not resolved"]},{"year":2019,"claim":"Provided structural insight into the H1X N-terminal domain, showing it adopts transient alpha-helical structure under DNA-mimicking high ionic strength.","evidence":"Solution NMR backbone resonance assignment and chemical shift analysis","pmids":["30868366"],"confidence":"Medium","gaps":["Functional role of induced helicity inferred, not directly tested on DNA","No full-length structure in chromatin context"]},{"year":2022,"claim":"Defined the molecular mechanism of H1X chaperoning, showing TAF-Iβ binds the globular domain electrostatically in a 2:2 complex that occludes DNA-binding sites to prevent premature chromatin deposition.","evidence":"Methyl-TROSY NMR with spin labels, binding assays, structure-guided mutagenesis, and structural modeling","pmids":["35870650"],"confidence":"High","gaps":["How TAF-Iβ hands off H1X for deposition not resolved","Cellular regulation of the chaperone interaction not established"]},{"year":2024,"claim":"Demonstrated a direct genome-protective function, showing H1X occupancy at recently incorporated transposable elements is required to keep SVA and Alu elements repressed.","evidence":"ChIP-Seq and H1X depletion with transposable element expression analysis across cell lines","pmids":["38261975"],"confidence":"High","gaps":["How H1X distinguishes recent TEs from older ones unknown","Cofactors mediating TE silencing not identified"]},{"year":2024,"claim":"Confirmed and extended H1X subnuclear localization, linking its nucleolar enrichment specifically to active rDNA transcription in a variant-distinct manner.","evidence":"Super-resolution microscopy and rDNA transcription inhibition across multiple human cell lines","pmids":["38530350"],"confidence":"Medium","gaps":["Functional role of H1X at rDNA not defined","Mechanism coupling H1X to rDNA transcription state unknown"]},{"year":2024,"claim":"Identified an upstream regulatory and disease axis, showing MEF2D directly activates H1X transcription downstream of IL-13/IL13RA1 to promote β-CATENIN and gastric cancer metastasis.","evidence":"ChIP, promoter-binding assays, overexpression/knockdown, proteomics, and mouse metastasis models","pmids":["38609001"],"confidence":"Medium","gaps":["How elevated H1X mechanistically drives β-CATENIN upregulation not resolved","Chromatin targets mediating the metastatic program not mapped"]},{"year":2024,"claim":"Tested whether elevated H1X is causally sufficient for stress-related behavioral adaptation, finding hippocampal overexpression alone produces no behavioral phenotype.","evidence":"Viral vector overexpression in mouse ventral hippocampus with chronic social defeat stress and behavioral testing","pmids":["38834575"],"confidence":"Medium","gaps":["Negative result does not exclude a context-dependent or partner-dependent role","Did not assess chromatin or transcriptional changes from overexpression"]},{"year":null,"claim":"How H1X is specifically targeted to high-GC A-compartment regions, recent transposable elements, and nucleoli, and how its deposition is regulated in vivo beyond TAF-Iβ, remain unresolved.","evidence":"No direct evidence in the available corpus","pmids":[],"confidence":"Low","gaps":["Targeting determinants for compartment-specific deposition unknown","Post-translational modifications and their regulatory roles uncharacterized","Downstream effectors of H1X-mediated repression not identified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,3]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,3,6]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[1,7]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[0,3,6]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[3,6,7]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,3,8]}],"complexes":["TAF-Iβ–H1X 2:2 complex"],"partners":["SET (TAF-IΒ)","MEF2D"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q92522","full_name":"Histone H1.10","aliases":["Histone H1x"],"length_aa":213,"mass_kda":22.5,"function":"Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber (PubMed:33238161). Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers and promote formation of the H3K27me3 mark by the PRC2/EED-EZH2 complex (PubMed:33238161, PubMed:40516528)","subcellular_location":"Nucleus; Nucleus, nucleolus; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q92522/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/H1-10","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CTCF","stoichiometry":10.0},{"gene":"MYO1E","stoichiometry":10.0},{"gene":"NUCKS1","stoichiometry":10.0},{"gene":"NUMA1","stoichiometry":10.0},{"gene":"RPL11","stoichiometry":10.0},{"gene":"RPL19","stoichiometry":10.0},{"gene":"RPL4","stoichiometry":10.0},{"gene":"RPL5","stoichiometry":10.0},{"gene":"RPS16","stoichiometry":10.0},{"gene":"SRP68","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/search/H1-10","total_profiled":1310},"omim":[],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli","reliability":"Supported"},{"location":"Nucleoli rim","reliability":"Additional"},{"location":"Mitotic chromosome","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":948.8}],"url":"https://www.proteinatlas.org/search/H1-10"},"hgnc":{"alias_symbol":["MGC15959","MGC8350","H1X"],"prev_symbol":["H1FX"]},"alphafold":{"accession":"Q92522","domains":[{"cath_id":"1.10.10.10","chopping":"48-123","consensus_level":"high","plddt":92.9233,"start":48,"end":123}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92522","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92522-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92522-F1-predicted_aligned_error_v6.png","plddt_mean":64.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=H1-10","jax_strain_url":"https://www.jax.org/strain/search?query=H1-10"},"sequence":{"accession":"Q92522","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92522.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92522/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92522"}},"corpus_meta":[{"pmid":"25645921","id":"PMC_25645921","title":"Genome distribution of replication-independent histone H1 variants shows H1.0 associated with nucleolar domains and H1X associated with RNA polymerase II-enriched regions.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25645921","citation_count":58,"is_preprint":false},{"pmid":"16006241","id":"PMC_16006241","title":"Characterisation of human histone H1x.","date":"2005","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16006241","citation_count":53,"is_preprint":false},{"pmid":"17868027","id":"PMC_17868027","title":"G1 phase-dependent nucleolar accumulation of human histone H1x.","date":"2007","source":"Biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/17868027","citation_count":37,"is_preprint":false},{"pmid":"19108733","id":"PMC_19108733","title":"Histone H1x is highly expressed in human neuroendocrine cells and tumours.","date":"2008","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19108733","citation_count":24,"is_preprint":false},{"pmid":"32760225","id":"PMC_32760225","title":"A newly identified lncRNA H1FX-AS1 targets DACT1 to inhibit cervical cancer via sponging miR-324-3p.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/32760225","citation_count":15,"is_preprint":false},{"pmid":"20974140","id":"PMC_20974140","title":"Evidence for a dynamic role of the linker histone variant H1x during retinoic acid-induced differentiation of NT2 cells.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20974140","citation_count":13,"is_preprint":false},{"pmid":"38609001","id":"PMC_38609001","title":"MEF2D facilitates liver metastasis of gastric cancer cells through directly inducing H1X under IL-13 stimulation.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38609001","citation_count":9,"is_preprint":false},{"pmid":"28766996","id":"PMC_28766996","title":"Temporally and Spatially Regulated Expression of the Linker Histone H1fx During Mouse Development.","date":"2017","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/28766996","citation_count":7,"is_preprint":false},{"pmid":"38530350","id":"PMC_38530350","title":"Imaging analysis of six human histone H1 variants reveals universal enrichment of H1.2, H1.3, and H1.5 at the nuclear periphery and nucleolar H1X presence.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/38530350","citation_count":5,"is_preprint":false},{"pmid":"38261975","id":"PMC_38261975","title":"Genomic profiling of six human somatic histone H1 variants denotes that H1X accumulates at recently incorporated transposable elements.","date":"2024","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/38261975","citation_count":5,"is_preprint":false},{"pmid":"30868366","id":"PMC_30868366","title":"NMR assignments of human linker histone H1x N-terminal domain and globular domain in the presence and absence of perchlorate.","date":"2019","source":"Biomolecular NMR assignments","url":"https://pubmed.ncbi.nlm.nih.gov/30868366","citation_count":2,"is_preprint":false},{"pmid":"35870650","id":"PMC_35870650","title":"Structural Mechanism of TAF-Iβ Chaperone Function on Linker Histone H1.10.","date":"2022","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/35870650","citation_count":2,"is_preprint":false},{"pmid":"38834575","id":"PMC_38834575","title":"Histone H1x in mouse ventral hippocampus associates with, but does not cause behavioral adaptations to stress.","date":"2024","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/38834575","citation_count":0,"is_preprint":false},{"pmid":"37986938","id":"PMC_37986938","title":"Histone H1x in mouse ventral hippocampus correlates with, but does not cause behavioral adaptations to stress.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37986938","citation_count":0,"is_preprint":false},{"pmid":"32642505","id":"PMC_32642505","title":"Raw nuclear magnetic resonance data of human linker histone H1x, lacking the C-terminal domain (NGH1x), and trajectory data of nanosecond molecular dynamics simulations of GH1x- and NGH1x-chromatosomes.","date":"2020","source":"Data in brief","url":"https://pubmed.ncbi.nlm.nih.gov/32642505","citation_count":0,"is_preprint":false},{"pmid":"41620781","id":"PMC_41620781","title":"H1FX as a novel biomarker linking pan-apoptosis to immune dysregulation in allergic rhinitis.","date":"2026","source":"European journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/41620781","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":9440,"output_tokens":2598,"usd":0.033645,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9932,"output_tokens":3261,"usd":0.065592,"stage2_stop_reason":"end_turn"},"total_usd":0.099237,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"H1X (H1x) localizes to the nucleus and is partially associated with nucleosomes; it is predominantly found in chromatin regions resistant to micrococcal nuclease digestion, resembling the distribution of the replacement histone H1.0. Its gene is solitarily located and produces polyadenylated mRNA, but unlike H1.0, its expression is not induced by growth arrest or differentiation.\",\n      \"method\": \"Cell fractionation, micrococcal nuclease digestion, mRNA analysis (biochemical characterization)\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical methods (fractionation, MNase digestion, mRNA analysis) in a single study; directly characterizes H1X chromatin association and expression regulation\",\n      \"pmids\": [\"16006241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"H1X undergoes a cell-cycle-dependent change in nuclear distribution: it accumulates in the nucleolus (specifically in condensed nucleolar chromatin) during G1 phase and is evenly distributed throughout the nucleus during S and G2 phases. The amount of H1X protein remains nearly unchanged during S phase, in contrast to replication-dependent H1 subtypes.\",\n      \"method\": \"Immunocytochemistry, cell synchronization, cell-cycle staging\",\n      \"journal\": \"Biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct imaging with cell-cycle synchronization in a single lab, multiple cell-cycle stages examined, clear functional implication of compartment shuttling as regulatory mechanism\",\n      \"pmids\": [\"17868027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"During retinoic acid-induced differentiation of NT2 embryonal carcinoma cells, H1X is preferentially incorporated into the regulatory region of the Nanog gene (a stemness marker that is repressed upon differentiation), suggesting a repressive role for H1X at this locus.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) coupled with real-time PCR, Western blot\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, ChIP-qPCR demonstrates H1X occupancy at Nanog promoter correlated with gene repression during differentiation; mechanistic link inferred but not fully dissected\",\n      \"pmids\": [\"20974140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ChIP-sequencing and cell fractionation in human breast cancer cells revealed that H1X is associated with coding regions, RNA polymerase II-enriched regions, and hypomethylated CpG islands; it accumulates within constitutive or included exons and retained introns and toward the 3' end of expressed genes. H1X knockdown dysregulates a subset of genes related to cell movement and transport; up-regulated genes in H1X-depleted cells have lower-than-average H1 content and do not form an H1 valley upon induction.\",\n      \"method\": \"ChIP-sequencing, cell fractionation, inducible knockdown, gene expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-Seq plus functional knockdown with defined transcriptional phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"25645921\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NMR backbone resonance assignments of the H1X N-terminal domain and globular domain show that the N-terminal domain adopts transient alpha-helical secondary structural elements at high ionic strength (in the presence of sodium perchlorate), suggesting the N-terminal domain can assume structured conformations in conditions mimicking the presence of DNA.\",\n      \"method\": \"Solution NMR (backbone resonance assignment, chemical shift analysis)\",\n      \"journal\": \"Biomolecular NMR assignments\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — NMR structural characterization in a single study; functional consequence is inferred from chemical shift changes rather than directly tested\",\n      \"pmids\": [\"30868366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The histone chaperone TAF-Iβ recognizes H1.10 (H1X) in a 2:2 complex; the TAF-Iβ core interacts mainly through electrostatic interactions with the globular domain of H1.10. Structure-guided mutagenesis confirmed these interactions. The structural model shows that TAF-Iβ occludes the DNA-binding sites of H1.10, providing the mechanism by which TAF-Iβ functions as a chaperone by preventing H1.10 from directly binding DNA.\",\n      \"method\": \"Methyl-TROSY NMR with spin labels, biochemical binding assays, mutagenesis, structural modeling, comparison with chromatosome structure\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR-derived structural model with mutagenesis confirmation and mechanistic explanation (DNA-site occlusion); multiple orthogonal biophysical and biochemical methods in a single rigorous study\",\n      \"pmids\": [\"35870650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ChIP-Seq profiling in a breast cancer cell line shows H1X preferentially localizes in high-GC regions (A compartment) and is enriched at recently incorporated transposable elements (SVA and SINE-Alu families). H1X depletion leads to derepression of these transposable elements, demonstrating a direct role for H1X in maintaining TE repression.\",\n      \"method\": \"ChIP-Seq, H1X knockdown/depletion, transposable element expression analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-Seq combined with functional depletion showing TE derepression, consistent across multiple cell lines; replicated genomic localization finding from earlier ChIP-Seq study\",\n      \"pmids\": [\"38261975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Super-resolution imaging and imaging analysis in multiple human cell lines show that H1X is distributed throughout the nucleus and is universally enriched in high-GC regions and in nucleoli. H1X (but not other H1 variants) shows a distinct response to inhibition of ribosomal DNA transcription, linking its nucleolar enrichment to active rDNA transcription. H1 variant depletion affects chromatin structure in a variant-specific manner.\",\n      \"method\": \"Super-resolution microscopy, immunofluorescence, rDNA transcription inhibition, multiple cell lines\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by super-resolution microscopy across multiple cell lines with functional perturbation (rDNA transcription inhibition); single lab but multiple orthogonal imaging approaches\",\n      \"pmids\": [\"38530350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MEF2D transcription factor directly binds the H1X promoter and drives transcriptional activation of H1X in gastric cancer cells. H1X upregulation in turn promotes in vivo metastasis of gastric cancer cells and upregulates β-CATENIN. The IL-13/IL13RA1 signaling axis induces MEF2D and H1X expression in a time-dependent manner.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), promoter-binding assay, overexpression/knockdown, proteomics, mouse metastasis models, quantitative RT-PCR\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrates direct MEF2D binding to H1X promoter; functional consequence shown by OE/KD in mouse models; single lab with multiple methods\",\n      \"pmids\": [\"38609001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Overexpression of H1X in the mouse ventral hippocampus via viral vector does not produce behavioral changes (social, anxiety-like, or memory tests) in susceptible, resilient, or unstressed mice, indicating that elevated H1X alone is not sufficient to drive behavioral adaptations to chronic social stress.\",\n      \"method\": \"Viral vector overexpression in vivo, chronic social defeat stress paradigm, behavioral testing\",\n      \"journal\": \"Translational psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct in vivo gain-of-function experiment with clear negative behavioral result; single lab, single approach; negative finding is mechanistically informative (H1X elevation is not causally sufficient)\",\n      \"pmids\": [\"38834575\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"H1X (H1-10) is a replication-independent linker histone variant that associates with nucleosomes in micrococcal nuclease-resistant chromatin, preferentially occupies high-GC genomic regions (A compartment), RNA Pol II-enriched gene bodies, and nucleoli, and undergoes cell-cycle-dependent nucleolar accumulation during G1; its chaperone TAF-Iβ binds the H1X globular domain via electrostatic interactions in a 2:2 complex that occludes DNA-binding sites, thereby regulating H1X deposition onto chromatin, while H1X itself represses recently incorporated transposable elements (SVA and Alu) and contributes to gene regulation—including repression at the Nanog locus during differentiation—and its transcription is directly activated by MEF2D downstream of IL-13/IL13RA1 signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"H1-10 (H1X) is a replication-independent linker histone variant that partitions into specific genomic compartments to shape chromatin structure and gene regulation [#0, #3]. Unlike replication-dependent H1 subtypes, its abundance is stable through S phase, and it shuttles into nucleolar chromatin during G1 phase [#1], with nucleolar enrichment coupled to active rDNA transcription [#7]. Genome-wide profiling places H1X in high-GC, RNA polymerase II-enriched coding regions and hypomethylated CpG islands, biased toward exons and the 3' ends of expressed genes, where its depletion dysregulates genes linked to cell movement and transport [#3]. H1X preferentially occupies high-GC A-compartment regions and recently incorporated transposable elements, and its loss derepresses SVA and SINE-Alu elements, establishing a direct role in transposon silencing [#6]; it likewise contributes to locus-specific repression, occupying the Nanog regulatory region during retinoic acid-induced differentiation [#2]. Deposition of H1X onto chromatin is governed by the histone chaperone TAF-I\\u03b2, which binds the H1X globular domain through electrostatic contacts in a 2:2 complex that occludes its DNA-binding sites [#5]. H1X transcription is directly activated by MEF2D downstream of IL-13/IL13RA1 signaling, driving \\u03b2-CATENIN upregulation and gastric cancer metastasis [#8].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Established H1X as a distinct linker histone variant by showing it associates with MNase-resistant chromatin like H1.0 yet, unlike H1.0, is not induced by growth arrest or differentiation.\",\n      \"evidence\": \"Cell fractionation, MNase digestion, and mRNA analysis\",\n      \"pmids\": [\"16006241\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not define genomic targets or chromatin compartments occupied\", \"Regulatory function not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Revealed cell-cycle-dependent subnuclear dynamics, showing H1X accumulates in nucleolar chromatin during G1 while remaining stable in abundance through S phase, distinguishing it from replication-coupled H1.\",\n      \"evidence\": \"Immunocytochemistry with cell synchronization across cell-cycle stages\",\n      \"pmids\": [\"17868027\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism driving G1 nucleolar relocalization unknown\", \"Functional consequence of nucleolar accumulation not established\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Linked H1X to locus-specific gene repression by showing it is incorporated into the Nanog regulatory region as the gene is silenced during differentiation.\",\n      \"evidence\": \"ChIP-qPCR and Western blot in retinoic acid-differentiated NT2 cells\",\n      \"pmids\": [\"20974140\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal repressive role inferred from occupancy correlation, not direct perturbation\", \"Recruitment mechanism to Nanog locus unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the genome-wide distribution of H1X, placing it in RNA Pol II-enriched coding regions and hypomethylated CpG islands and tying its depletion to a defined transcriptional phenotype.\",\n      \"evidence\": \"ChIP-Seq, cell fractionation, and inducible knockdown with expression profiling in breast cancer cells\",\n      \"pmids\": [\"25645921\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify how H1X is targeted to these regions\", \"Direct vs indirect effects on dysregulated genes not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Provided structural insight into the H1X N-terminal domain, showing it adopts transient alpha-helical structure under DNA-mimicking high ionic strength.\",\n      \"evidence\": \"Solution NMR backbone resonance assignment and chemical shift analysis\",\n      \"pmids\": [\"30868366\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional role of induced helicity inferred, not directly tested on DNA\", \"No full-length structure in chromatin context\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined the molecular mechanism of H1X chaperoning, showing TAF-I\\u03b2 binds the globular domain electrostatically in a 2:2 complex that occludes DNA-binding sites to prevent premature chromatin deposition.\",\n      \"evidence\": \"Methyl-TROSY NMR with spin labels, binding assays, structure-guided mutagenesis, and structural modeling\",\n      \"pmids\": [\"35870650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TAF-I\\u03b2 hands off H1X for deposition not resolved\", \"Cellular regulation of the chaperone interaction not established\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrated a direct genome-protective function, showing H1X occupancy at recently incorporated transposable elements is required to keep SVA and Alu elements repressed.\",\n      \"evidence\": \"ChIP-Seq and H1X depletion with transposable element expression analysis across cell lines\",\n      \"pmids\": [\"38261975\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How H1X distinguishes recent TEs from older ones unknown\", \"Cofactors mediating TE silencing not identified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Confirmed and extended H1X subnuclear localization, linking its nucleolar enrichment specifically to active rDNA transcription in a variant-distinct manner.\",\n      \"evidence\": \"Super-resolution microscopy and rDNA transcription inhibition across multiple human cell lines\",\n      \"pmids\": [\"38530350\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional role of H1X at rDNA not defined\", \"Mechanism coupling H1X to rDNA transcription state unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified an upstream regulatory and disease axis, showing MEF2D directly activates H1X transcription downstream of IL-13/IL13RA1 to promote \\u03b2-CATENIN and gastric cancer metastasis.\",\n      \"evidence\": \"ChIP, promoter-binding assays, overexpression/knockdown, proteomics, and mouse metastasis models\",\n      \"pmids\": [\"38609001\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How elevated H1X mechanistically drives \\u03b2-CATENIN upregulation not resolved\", \"Chromatin targets mediating the metastatic program not mapped\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Tested whether elevated H1X is causally sufficient for stress-related behavioral adaptation, finding hippocampal overexpression alone produces no behavioral phenotype.\",\n      \"evidence\": \"Viral vector overexpression in mouse ventral hippocampus with chronic social defeat stress and behavioral testing\",\n      \"pmids\": [\"38834575\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Negative result does not exclude a context-dependent or partner-dependent role\", \"Did not assess chromatin or transcriptional changes from overexpression\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How H1X is specifically targeted to high-GC A-compartment regions, recent transposable elements, and nucleoli, and how its deposition is regulated in vivo beyond TAF-I\\u03b2, remain unresolved.\",\n      \"evidence\": \"No direct evidence in the available corpus\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Targeting determinants for compartment-specific deposition unknown\", \"Post-translational modifications and their regulatory roles uncharacterized\", \"Downstream effectors of H1X-mediated repression not identified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 3, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [1, 7]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [0, 3, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [3, 6, 7]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 3, 8]}\n    ],\n    \"complexes\": [\n      \"TAF-I\\u03b2\\u2013H1X 2:2 complex\"\n    ],\n    \"partners\": [\n      \"SET (TAF-I\\u03b2)\",\n      \"MEF2D\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}